Fletta eftir höfundi "Sartipy, Ulrik"

Atriði 1-2 af 2

Dual or single antiplatelet therapy after coronary surgery for acute coronary syndrome (TACSI trial) : Rationale and design of an investigator-initiated, prospective, multinational, registry-based randomized clinical trial

Malm, Carl Johan; Alfredsson, Joakim; Erlinge, David; Guðbjartsson, Tómas; Gunn, Jarmo; James, Stefan; Møller, Christian H; Nielsen, Susanne J; Sartipy, Ulrik; Tønnessen, Theis; Jeppsson, Anders (2023-05)

The TACSI trial (ClinicalTrials.gov Identifier: NCT03560310) tests the hypothesis that 1-year treatment with dual antiplatelet therapy with acetylsalicylic acid (ASA) and ticagrelor is superior to only ASA after isolated coronary artery bypass grafting ...
Survival after aortic root replacement with a stentless xenograft is determined by patient characteristics

Dagnegård, Hanna H.; Bekke, Kirstine; Kolseth, Solveig M.; Glaser, Natalie; Wallén, Christoffer; El-Hamamsy, Ismail; Víðisson, Kristján O.; Lie, Asbjørn S.; Valentin, Jan B.; Sartipy, Ulrik; Haaverstad, Rune; Vanky, Farkas; Lefebvre, Laurence; Guðbjartsson, Tómas; Johnsen, Søren P.; Søndergaard, Lars; Thyregod, Gustav H.; Lund, Jens T.; Ihlemann, Nikolaj; Smerup, Morten H. (2021)

Objectives: Our objective was to examine intermediate-term survival and reinterventions in unselected patients, stratified according to indication, who received a Freestyle (Medtronic Inc, Minneapolis, Minn) bioprosthesis as a full aortic root replacement. ...

Atriði 1-2 af 2

Leita